Regulations.gov document
Reference 1 - "Guidance for Industry & FDA Staff: Early Development Considerations for…
Supporting & Related Material · FDA-2009-D-0132 · posted Nov 8, 2010
Key facts
| Document ID | FDA-2009-D-0132-0014 |
|---|---|
| Title | Reference 1 - "Guidance for Industry & FDA Staff: Early Development Considerations for Innovative Combination Products (September 2006)" - [Guidance for Industry; Availability: Cellular Therapy for Cardiac Disease] |
| Document type | Supporting & Related Material |
| Subtype | REF-Reference (internal unless indicated) |
| Agency | FDA |
| Docket | FDA-2009-D-0132 |
| Posted | Nov 8, 2010 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: